Patient Identifying Information Clause Samples
The Patient Identifying Information clause defines how personal data that can identify a patient is handled within an agreement or policy. It typically outlines what constitutes identifying information—such as names, medical record numbers, or contact details—and sets rules for its collection, use, and disclosure. This clause is essential for protecting patient privacy and ensuring compliance with legal and regulatory requirements, such as HIPAA, by clearly delineating responsibilities and limitations regarding sensitive health information.
Patient Identifying Information. All parties to this Agreement shall comply with all applicable state and federal laws and regulations regarding confidentiality of patient records, including but not limited to the Health Insurance Portability and Accountability Act of 1996 (“HIPAA”) and the Privacy and Security Standards (45 C.F.R. Parts 160 and 164) and the Standards for Electronic Transactions (45 C.F.R. Parts 160 and 162) (collectively, the “Standards”) promulgated or to be promulgated by the Secretary of Health and Human Services on and after the applicable effective dates specified in the Standards. All medical information and data concerning specific patients, including but not limited to the identity of the patients, derived from the business relationship set forth in this Agreement shall be treated and maintained in a confidential manner by all parties to this Agreement and shall not be released, disclosed, or published to any party other than as required or permitted under applicable laws. All parties agree to the Business Associate Agreement attached to this Agreement as Exhibit E and shall comply with the provisions set forth therein.
Patient Identifying Information. SAMPLE All medical information and data concerning specific patients (including, but not limited to, the identity of the patients), derived from or obtained during the course of providing professional medical services under this Agreement, shall be treated and maintained in a confidential manner by RESIDENT. All parties to this AGREEMENT shall comply with all applicable federal, state and local laws and regulations regarding confidentiality of patient records, including but not limited to the Health Insurance Portability and Accountability Act of 1996 (“HIPAA”) and the Privacy Standards (45 C.F.R. Parts 160 and 164), the Standards for Electronic Transactions (45 C.F.R. Parts 160 & 162) and the Security Standards (45 C.F.R. Part 142) (collectively, the “Standards”) promulgated or to be promulgated by the Secretary of Health and Human Services on and after the applicable effective dates specified in the Standards, and shall not be released, disclosed or published to any party other than as required or permitted under applicable laws.
Patient Identifying Information. The term “Patient Identifying Information” means the name, address, Social Security number, fingerprints, photograph, or similar information by which the identity of a patient (whether current or former) who has applied for or been given diagnosis, treatment, or referral for treatment for a substance use disorder can be determined with reasonable accuracy either directly or by reference to other information.
Patient Identifying Information. All medical information and data concerning specific patients (including, but not limited to, the identity of the patients), derived from the business relationship set forth in this Agreement, shall be treated and maintained in a confidential manner by all parties to this Agreement and their employees and agents and shall not be released, disclosed, or published to any party other than as required or permitted under applicable laws. All parties to this Agreement shall comply with all applicable state and federal laws and regulations regarding confidentiality of patient records, including but not limited to the Health Insurance Portability and Accountability Act of 1996 (“HIPAA”) and the Privacy Standards (45 C.F.R. Parts 160 and 164), the Standards for Electronic Transactions (45 C.F.R. Parts 160 and 162) and the Security Standards (45 C.F.R. Part 162) (collectively, the “Standards”) promulgated or to be promulgated by the Secretary of Health and Human Services on and after the applicable effective dates specified in the Standards. Talyst agrees to sign a Business Associate Agreement with ▇▇▇▇▇▇▇▇, as mutually agreed upon by the parties. Notwithstanding the above, Customer shall be the data controller of its personally identifiable health information at all times.
Patient Identifying Information. The parties shall comply with all applicable state and federal laws and regulations regarding confidentiality of patient records, including but not limited to the Health Insurance Portability and Accountability Act of 1996 and the Privacy and Security Standards (45 C.F.R. Parts 160 and 164), the Standards for Electronic Transactions (45 C.F.R. Parts 160 and 162), and 42 C.F.R. Part 2 (collectively, the “Standards”) promulgated or to be promulgated by the Secretary of Health and Human Services. To the extent applicable, all medical information and data concerning specific patients (including, but not limited to, the identity of the patients), derived from the business relationship set forth in this Agreement, shall be treated and maintained in a confidential manner by the parties to this Agreement and their employees and agents and shall not be released, disclosed, or published to any party other than as required or permitted under applicable laws. It is not the intent of the parties that the District becomes a Business Associate of Clarity. However, to the extent the parties mutually agree otherwise, the District and Clarity shall execute a HIPAA-compliant Business Associate Agreement (“Business Associate Agreement”). In the event of any conflict between the terms of the Business Associate Agreement and this Agreement, the Business Associate Agreement will govern.
Patient Identifying Information. All medical information and data concerning specific patients (including, but not limited to, the identity of the patients), derived from the business relationship set forth in this Agreement, shall be treated and maintained in a confidential manner by the parties to this Agreement and their employees and agents and shall not be released, disclosed, or published to any party other than as required or permitted under applicable laws. The parties to this Agreement shall comply with all applicable state and federal laws and regulations regarding confidentiality of patient records, including but not limited to the Health Insurance Portability and Accountability Act of 1996 and the Privacy and Security Standards (45 C.F.R. Parts 160 and 164) and the Standards for Electronic Transactions (45 C.F.R. Parts 160 and 162) (collectively, the “Standards”) promulgated or to be promulgated by the Secretary of Health and Human Services. To the extent either party believes the Standards require any additional agreement regarding the access to Protected Health Information, both parties agree to sign any such additional agreement. In the event either party requests the other party to sign such an agreement and the other party refuses, the party shall have the right to immediately terminate this Agreement.
Patient Identifying Information. The parties to this Agreement shall comply with all applicable state and federal laws and regulations regarding confidentiality of patient records, including but not limited to the Health Insurance Portability and Accountability Act of 1996 and the Privacy and Security Standards (45 C.F.R. Parts 160 and 164) and the Standards for Electronic Transactions (45 C.F.R. Parts 160 and 162) (collectively, the “Standards”) promulgated or to be promulgated by the Secretary of Health and Human Services. To the extent applicable, all medical information and data concerning specific patients (including, but not limited to, the identity of the patients), derived from the business relationship set forth in this Agreement, shall be treated and maintained in a confidential manner by the parties to this Agreement and their employees and agents and shall not be released, disclosed, or published to any party other than as required or permitted under applicable laws. To the extent School District becomes a Business Associate of Youth Bridge, School District and Youth Bridge shall execute a HIPAA Business Associate Agreement (“Business Associate Agreement”). In the event of any conflict between the terms of the Business Associate Agreement and this Agreement, the Business Associate Agreement will govern.
Patient Identifying Information. The parties to this Agreement shall comply with all applicable state and federal laws and regulations regarding confidentiality of patient records, including but not limited to the Health Insurance Portability and Accountability Act of 1996 and the Privacy and Security Standards (45 C.F.R. Parts 160 and 164) and the Standards for Electronic Transactions (45 C.F.R. Parts 160 and 162) (collectively, the “Standards”) promulgated or to be promulgated by the Secretary of Health and Human Services. To the extent applicable, all medical information and data concerning specific patients (including, but not limited to, the identity of the patients), derived from the business relationship set forth in this Agreement, shall be treated and maintained in a confidential manner by the parties to this Agreement and their employees and agents and shall not be released, disclosed, or published to any party other than as required or permitted under applicable laws. To the extent School District becomes a Business Associate of PFH, School District and PFH shall execute a HIPAA Business Associate Agreement (“Business Associate Agreement”). In the event of any conflict between the terms of the Business Associate Agreement and this Agreement, the Business Associate Agreement will govern. Further, PFH agrees to meet the requirements of the federal regulations governing Protected Health Information and Alcohol and Drug Abuse Patient Records, (see HIPAA Privacy Rule 45 C.F.R. Part 160 and subparts A and E and 42 C.F.R. Part 2), in regards to receiving, storing, processing or otherwise dealing with any information about students receiving school-based substance abuse intervention and education services. PFH will undertake to resist in judicial proceedings any effort to obtain access to information pertaining to patients otherwise than as expressly provided for in the federal confidentiality regulations, 42 C.F.R. Part 2. Written client consent for release of confidential alcohol and drug abuse information must be obtained before PFH can share consumer specific information with School District.
Patient Identifying Information. “Patient Identifying Information” shall have the same meaning as the term “Patient Identifying Information” in 42 CFR 2.11.
Patient Identifying Information. The parties to this Agreement shall comply with all applicable state and federal laws and regulations regarding confidentiality of patient records, including but not limited to the Health Insurance Portability and Accountability Act of 1996 and the Privacy and Security Standards (45 C.F.R. Parts 160 and 164) and the Standards for Electronic Transactions (45 C.F.R. Parts 160 and 162) (collectively, the “Standards”) promulgated or to be promulgated by the Secretary of Health and Human Services. To the extent applicable, all medical information and data concerning specific patients (including, but not limited to, the identity of the patients), derived from the business relationship set forth in this Agreement, shall be treated and maintained in a confidential manner by the parties to this Agreement and their employees and agents and shall not be released, disclosed, or published to any party other than as required or permitted under applicable laws.